|

Oregano and Basil Leaves and Coronary Artery Disease

RECRUITINGN/ASponsored by Shahid Beheshti University of Medical Sciences
Actively Recruiting
PhaseN/A
SponsorShahid Beheshti University of Medical Sciences
Started2025-09-01
Est. completion2026-03-17
Eligibility
Age30 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07123181

Summary

The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.

Eligibility

Age: 30 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients diagnosed with unstable angina

Exclusion Criteria:

* Patients diagnosed with STEMI
* Patients undergoing coronary artery bypass grafting
* Liver cirrhosis and advanced chronic kidney disease (CKD 5)
* Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid medications
* Pregnancy or breastfeeding

Conditions3

Acute Coronary SyndromesHeart DiseaseUnstable Angina (UA)

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.